why choose us

First received: February 17, 2023

Clinical Trial: Second Window Indocyanine Green for All Nervous System Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Nervous System Tumor

Study Type: INTERVENTIONAL


Official Title: Intraoperative Molecular Imaging of Central Nervous System Tumors Using Same Day Second Window Imaging With Indocyanine Green (TumorGlow™ - CNS)

Brief Summary: The study is being conducted to determine if a same-day, low-dose intravenous (into a vein) injection of indocyanine green (ICG) (FDA-approved dye) being detected by using an imaging system can be a useful tool in identifying and differentiating tumor tissue from normal tissues.

Read more